Toxicity of diclofenac and its biotransformation by Raoultella sp. DD4

• Autorzy: Domaradzka D. , Guzik U. , Hupert-Kocurek K. , Wojcieszynska D.
• Języki publikacji: EN

Abstrakty

EN

In recent years the increased consumption of diclofenac, a biologically active compound that is toxic to organisms and persistent to biodegradation, has resulted in its presence in the environment. This is the first report on the biotransformation of diclofenac by a pure bacterial strain, Raoultella sp. DD4, which is able to transform 0.6 mg/L of diclofenac in 28 days. Additionally, strain DD4 is more resistant to diclofenac than other tested organisms. The estimated value for EC50 for this strain is 1.95 g/L. This is approximately five-fold higher than the value of microbial toxic concentration MTCavg (0.416 g/L). Moreover, genotoxicity studies have indicated that diclofenac is not a mutagenic compound.

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2016
• Tom: 25
• Numer: 5
• Opis fizyczny: p.2211-2216,fig.,ref.

Twórcy

autor

Domaradzka D.

• Department of Biochemistry, Faculty of Biology and Environmental Protection, University of Silesia in Katowice, Jagiellonska 28, 40-032 Katowice, Poland

autor

Guzik U.

• Department of Biochemistry, Faculty of Biology and Environmental Protection, University of Silesia in Katowice, Jagiellonska 28, 40-032 Katowice, Poland

autor

Hupert-Kocurek K.

• Department of Biochemistry, Faculty of Biology and Environmental Protection, University of Silesia in Katowice, Jagiellonska 28, 40-032 Katowice, Poland

autor

Wojcieszynska D.

• Department of Biochemistry, Faculty of Biology and Environmental Protection, University of Silesia in Katowice, Jagiellonska 28, 40-032 Katowice, Poland

Bibliografia

• 1. European Commission. Brussels, 31.1.2012. Proposal for a Directive of the European Parliament and of the Council amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. COM(2011) 876 final.
• 2. CHEN J.B., GAO H.W., ZHANG Y.L., ZHANG Y., ZHOU X.F., LI CH.Q., GAO H.P. Developmental toxicity of diclofenac and elucidation of gene regulation in zebrafish (Danio rerio). Sci. Rep. 4, 4841, 2014.
• 3. MEMMERT U., PEITHER A., BURRI R., WEBER K., SCHMIDT T., SUMPTER J.P., HARTMANN A. Diclofenac: new data on chronic Toxicity and bioconcentration in fish. Environ. Toxicol. Chem. 32, 442, 2013.
• 4. LANGENHOFF A., INDERFURTH N., VEUSKENS T., SCHRAA G., BLOKLAND M., KUJAWA-ROELEVELD K., RIJNAARTS H. Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater. BioMed Res. Int. Article ID 325806, 9 pages, 2013.
• 5. KOSJEK T., HEATH E., PEREZ S., PETROVIC M., BARCELO D. Metabolism studies of diclofenac and clofibirc acid in activated sludge bioreactor using liquid chromatography with quadrupole – time-of-flight mass spectrometry. J. Hydrol. 372, 109, 2009.
• 6. DOMARADZKA D., GUZIK U., WOJCIESZYŃSKA D. Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs. Rev. Environ. Sci. Biotechnol. 14, 229, 2015.
• 7. HATA T., KAWAI S., OKAMURA H., NISHIDA T. Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation. Biodegradation 21, 681, 2010.
• 8. MARCO-URREA E., PEREZ-TRUJILLO M., CRUZMORATO C., CAMINAL G., VICENT T. Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR. J. Hazard. Mater. 176, 836, 2010.
• 9. RODARTE-MORALES A.I., FEIJOO G., MOREIRA M.T., LEMA J.M. Biotransformation of three pharmaceutical active compounds by the fungus Phanerochaete chrysosporium in a fed batch stirred reactor under air and oxygen supply. Biodegradation 23, 145, 2012.
• 10. GUZIK U., GREŃ I., WOJCIESZYŃSKA D., ŁABUŻEK S. Isolation and characterization of a novel strain of Stenotrophomonas maltophilia possessing various dioxygenases for monocyclic hydrocarbon degradation. Braz. J. Microbiol. 40, 285, 2009.
• 11. HOLT J.G., KRIEG N.R., SNEATH P.H.A., STALEY J.T., WILLIAMS S.T. Bergey’s manual of determinative bacteriology, Williams and Wilkins, USA, 1994.
• 12. GREŃ I., WOJCIESZYŃSKA D., GUZIK U., PERKOSZ M., HUPERT-KOCUREK K. Enhanced biotransformation of mononitrophenols by Stenotrophomonas malthophilia KB2 in the presence of aromatic compounds of plant origin. World J. Microbiol. Biotechnol. 26, 289, 2010.
• 13. BRONOWSKA M., STĘBOROWSKI R., BYSTRZEJEWSKA-PIOTROWSKA G. Estimation of the acute cesium toxicity by the microbial assay for risk assessment (MARA) test. Nukleonika 58, 481, 2013.
• 14. SIEROSLAWSKA A. Evaluation of usefulness of Microbial Assay for Risk Assessment (MARA) in the cyanobacterial toxicity estimation. Environ. Monit. Asses. 186, 4629, 2014.
• 15. WADHIA K. ISTA13 – international interlaboratory comparative evaluation of microbial assay for risk assessment (MARA). Environ. Toxicol. 23, 626, 2008.
• 16. FLÜCKIGER-ISLER S., BAUMEISTER M., BRAUN K., GERVAIS V., HASLER-NGUYEN N.H., REIMANN R., VAN GOMPEL J., WUNDERLICH H.G., ENGELHARDT G. Assessment of performance of the Ames IITM assay: a collaborative study with 19 coded compounds. Mutat. Res. 558, 181, 2004.
• 17. KRUGLOVA A., AHLGREN P., KORHONEN N., RANTANEN P., MIKOLA A., VAHALA R. Biodegradation of ibuprofen, diclofenac and carbamazepine in nitifying activated sludge under 12ºC temperature comditions. Sci. Total Environ. 499, 394, 2014.
• 18. FERRARI B., PAXEUS N, GIUDICE R.L., POLLIO A., GARRIC J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotox. Environ. Safe. 55, 359, 2003.
• 19. LAWRENCE J.R., SWERHONE G.D.W., TOPP E., KORBER D.R., NEU T.R., WASSENAAR L.I. Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory diclofenac. Environ. Toxicol. Chem. 26, 573, 2007.
• 20. CHERIK D., BENALI M., LOUHAB K. Occurrence, ecotoxicology, removal of diclofenac by adsorption on activated carbon and biodegradation and its effect on bacterial community: a review. World Sci. News 10, 116, 2015.
• 21. CLEUVERS M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylic acid. Ecotox. Environ. Safe. 59, 309, 2004.
• 22. ORTIZ DE GARCIA S.A., PINTO G.P., GARCIA-ENCINA P.A., IRUSTA-MATA R. Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants. Ecotoxicology 23, 1517, 2014.
• 23. LAH B., ZINKO B., TISLER T., MARINSEK-LOGAR R. Genotoxicity detection in drinking water by Ames test, Zimmerman test and comet assay. Acta Chim. Slov. 52, 341, 2005.
• 24. PHILIPOSE B., SINGH R., KHAN K.A., GIRI A.K. Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat. Res. 393, 123, 1997.
• 25. GRÖNING J., HELD C., GARTEN C., CLAUSSNITZER U., KASCHABEK S.R., SCHLOMANN M. Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere 69, 509, 2007.
• 26. LEE H.J., LEE E., YOON S.H., CHANG H.R., KIM K., KWON J.H. Enzymatic and microbial transformation assays for the evaluation of the environmental fate of diclofenac and its metabolites. Chemosphere 87, 969, 2012

Identyfikatory

DOI

10.15244/pjoes/62681